Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis
Predicts need for VTE prophylaxis in admitted patients.
Note: This score is distinct from the Geneva Score (Revised) for PE, which assesses the diagnostic probability of PE in patients presenting with relevant signs and symptoms.
Advice
- Use this tool alongside clinical judgment and not as a stand-alone determinant of prophylaxis decisions.
- Risk factors can change during hospitalization; reassess if the patient’s clinical status changes.
- Shared decision-making is encouraged, particularly when considering withholding pharmacologic prophylaxis in patients who appear high risk clinically or when new risk factors emerge later in the hospital course.
Management
- Low risk (score <3):
- Routine pharmacologic thromboprophylaxis is generally not indicated.
- Emphasize early mobilization and consider non-pharmacologic measures (e.g., compression stockings) if clinically indicated.
- Reassess the score if the patient’s clinical status changes.
- High risk (score ≥3):
- Initiate pharmacologic prophylaxis per local protocol (e.g., LMWH/UFH) after bleeding-risk assessment.
- Emphasize early mobilization and consider mechanical prophylaxis when pharmacologic agents are contraindicated or insufficient.
Refer to local protocols and guidelines for specific prophylaxis regimens and monitoring.
Critical Actions
- Always weigh bleeding risk before prescribing anticoagulant prophylaxis; consider a formal tool, such as the IMPROVE Bleeding Risk Score or VTE-BLEED Score.
- Do not withhold prophylaxis solely based on this score if clinical concern suggests the patient is at high risk for VTE or if local guidelines recommend broader prophylaxis.
- This tool does not account for all individual risk factors; use it as part of a comprehensive risk assessment.
- Be alert to signs and symptoms of VTE and bleeding and respond promptly according to institutional protocols.